Previous issue | Volume 84 | ESPE2015 | Next issue

54th Annual ESPE

Barcelona, Spain
01 Oct 2015 - 03 Oct 2015

Card image cap
Barcelona, Spain; 1-3 October 2015 Further information

Poster Presentations Poster Category 1


Immunohistochemical Detection of Estrogen [alpha] and Androgen Receptors in Genital Tissues in Girls with Congenital Adrenal Hyperplasia
aEndocrinology Research Center, Moscow, Russia; bLomonosov Moscow State University, Moscow, Russia; cScientific Centre of Children Health, Moscow, Russia
Attitudes of Parents of Klinefelter Boys and Flemish Paediatricians Towards Neonatal Screening and Fertility Preservation Techniques in Klinefelter Syndrome
aUZ Brussel, Division of Pediatric Endocrinology, Brussels, Belgium; bResearch Group Biology of the Testis, Department of Embryology and Genetics, Vrije Universiteit Brussel, Brussels, Belgium; cUZ Brussel, Centre for Reproductive Medicine, Brussels, Belgium
Long-term Endocrine Outcome in Men with Partial Androgen Insensitivity Syndrome
aUniversity of Glasgow, Glasgow, UK; bUniversity Hospital Pisa, Pisa, Italy; cUniversity of Copenhagen, Copenhagen, Denmark; dUniversity of Luebeck, Luebeck, Germany; eUniversity Hospital Schleswig-Holstein, Kiel, Germany; fUniversity Hospital Ghent, Ghent, Belgium; gTel Aviv University, Tel Aviv, Israel; hErasmus MC Sophia Children’s Hospital, Rotterdam, The Netherlands; iMarmara University, Istanbul, Turkey; jIstanbul University, Istanbul, Turkey; kKarolinska Institutet, Stockholm, Sweden; lUniversity of Cambridge, Cambridge, UK
Novel Genetic Associations in Children with Disorders of Sex Development and Neurodevelopment Disorders - Insights from the Deciphering Developmental Disorders study
aWest of Scotland Regional Genetics Service, Laboratory Medicine Building, Southern General Hospital, Glasgow, UK; bWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK; cSchool of Medicine, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, UK; dDevelopmental Endocrinology Research Group, Royal Hospital For Sick Children, University of Glasgow, Glasgow, UK
Current Models of Practice & Professional Development of Clinicians in DSD Centres - Results from an International Survey of Specialist Care for DSD
aDevelopmental Endocrinology Research Group, University of Glasgow, Glasgow, UK; bDepartment of Child and Adolescent Psychiatry, Erasmus MC – Sophia Children’s Hospital, Rotterdam, The Netherlands; cDepartment of Neuropsychiatry and Psychosomatic Medicine, Division of Surgery and Clinical Neuroscience, Oslo University Hospital, Oslo, Norway; dDepartment of Pediatrics and Medical Genetics, Medical University of Varna, Varna, Bulgaria; eDepartment of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; fDepartment of Medical Genetics, Poznan University of Medical Science, Poznan, Poland; gPaediatric Surgery, Astrid Lindgren Children Hospital, Karolinska University Hospital, Stockholm, Sweden; hGrApSIA (Grupo de Apoyo al Síndrome de Insensibilidad a los Andrógenos), Barcelona, Spain; iAlder Hey Children’s Hospital NHS Trust and University of Central Lancashire, Liverpool, UK; jDivision of Experimental Paediatric Endocrinology and Diabetes, University of Lübeck, Lübeck, Germany
Prediction of Germ Cell Cancer Occurrence in Postpubertal Individuals with Androgen Insensitivity Based on Pathological Findings and Cancer Predisposition SNPs
aGhent University, Ghent, Belgium; bGhent University Hospital, Ghent, Belgium; cSophia Children’s Hospital, Rotterdam, The Netherlands; dErasmus Medical Center, Rotterdam, The Netherlands; eJosephine Nefkens Institute, Rotterdam, The Netherlands; fCharles University and University Hospital Motol, Prague, Czech Republic; gFaculdade de Medicina, Universidade de Sao Paulo, Hospitals Clinicas, Sao Paolo, Brazil; hUniversitätsklinikum Schleswig-Holstein and Universität zu Lübeck, Lübeck, Germany; iIndiana University, Indianapolis, Indianapolis, USA; jClinical & Experimental Medicine University of Birmingham, Birmingham, UK
MAMLD1 Mutations Seem Not Sufficient to Explain a 46, XY DSD Phenotype. What else?
aPediatric Endocrinology and Diabetology, Department of Pediatrics and Department of Clinical Research, University Children’s Hospital Bern, Bern, Switzerland; bPediatric Endocrinology Research Unit, CIBERER (Center for Biomedical Research on Rare, Barcelona, VHIR (Vall d’Hebron Institut de Recerca), Universitat Autònoma de Barcelona, Hospital Universitari Vall d’Hebron, Spain; cPediatric Endocrinology, Hospital Infantil La Fe, Valencia, Spain; dPediatric Endocrinology, Hospital La Paz, Madrid, Spain; ePediatric Endocrinology, Hospital Materno-Infantil, Málaga, Spain; fPediatric Endocrinology, Corporació Parc Taulí, Hospital de Sabadell, Sabadell, Spain; gPediatric Endocrinology, Hospital Virgen Macarena, Sevilla, Spain; hPediatric Urology, Hospital Germans Trias-Pujol, Badalona, Spain
Subcutaneous Continuous Administration of Recombinant Human Luteinizing and Follicle-Stimulating Hormones is an Effective Treatment for Micropenis During the Mini-Puberty
aEndocrinologie, Gynécologie et Diabétologie Pédiatriques, Hôpital Universitaire Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France; bCentre des Maladies Endocriniennes Rares de la Croissance, Hôpital Universitaire Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France; cExplorations Fonctionnelles, Hôpital Universitaire Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France; dBiochimie et Hormonologie, Hôpital Universitaire Robert Debré, Assistance Publique-Hôpitaux de Paris, Paris, France; eRadiologie Pédiatrique, Hôpital Universitaire Necker Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France; fINSERM U1016, IMAGINE Institute, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
46, XX Ovotesticular DSD in the Absence of SRY Gene Associated to SOX3 Duplication
aCentro de Investigaciones Endocrinológicas Dr César Bergadá (CEDIE), CONICET-FEI-Division Endocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina; bÁrea de Genómica Estructural y Funcional Responsable de Calidad INGEMM – Instituto de Genética Médica y Molecular/Hospital Universitario La Paz, Madrid, Spain